Summary: Nyxoah SA, the maker of the CE-marked Genio neurostimulator system for obstructive sleep apnea, reported its financial and operational results for the second quarter and first half of 2024. The company has completed its FDA regulatory submission for Genio and expects a … [Read more...]
REMSleep Sets Goal to Capture 10% of CPAP Mask Market
Summary: REMSleep Holdings Inc announced a goal to capture 10% of the CPAP mask market within the next 24 months following the FDA approval of its DeltaWave nasal pillow mask. The company’s CEO says REMSleep aims to improve CPAP therapy compliance by addressing mask discomfort, a … [Read more...]
Vanda Highlights Q2 Efforts to Expand Hetlioz Amid Regulatory and Market Challenges
Summary: Vanda Pharmaceuticals reported its second-quarter 2024 financial and operational results, emphasizing efforts to expand the use of Hetlioz (tasimelteon) for pediatric insomnia and jet lag disorder. The company notes its financial performance was impacted by generic … [Read more...]